Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Rafael Pieretti-VanmarckeDavid T MacLaughlin

Abstract

Mullerian inhibiting substance (MIS) is a glycoprotein hormone that causes Mullerian duct regression in male embryos. In short-term experiments, recombinant human MIS (rhMIS) inhibits xenotransplanted human ovarian cancer cell lines that are thought to be of Mullerian origin. Because this highly lethal cancer has a high recurrence rate after conventional chemotherapy, new treatments are warranted. We examined whether rhMIS as a novel, nontoxic, naturally occurring growth inhibitor can be an effective anticancer drug in long-term studies in vivo against allograft tumors that recapitulate human ovarian carcinoma. Mouse ovarian carcinoma (MOVCAR) cell lines expressing the early region of the SV40 virus, including the large and small T-antigen genes under transcriptional control of a portion of the murine MIS receptor type II (MISRII) gene promoter, were derived from TgMISIIR-TAg transgenic mice. rhMIS was tested against MOVCAR cells in growth inhibition assays in vitro, and in vivo in 6-week-old female nude mice. Tumor growth in animals was measured at weekly intervals for up to 20 weeks. MOVCAR cells and tumors express MISRII by Western blot, immunohistochemical, and Northern blot analyses. rhMIS significantly inhibited MOVCAR ce...Continue Reading

References

Jul 1, 1977·The American Journal of Anatomy·J M PriceW H Hendren
Jan 1, 1990·The Journal of Clinical Endocrinology and Metabolism·P L HudsonD T MacLaughlin
Jan 1, 1990·The Journal of Clinical Endocrinology and Metabolism·M L BakerJ M Hutson
Jan 1, 1987·Cytogenetics and Cell Genetics·O Cohen-HaguenauerJ Frézal
Mar 1, 1970·Human Pathology·R E Scully
May 1, 1982·The Journal of Clinical Endocrinology and Metabolism·A F FullerP K Donahoe
Feb 1, 1993·Developmental Dynamics : an Official Publication of the American Association of Anatomists·W W HeP K Donahoe
Jan 1, 1997·CA: a Cancer Journal for Clinicians·S L ParkerP A Wingo
Aug 26, 2000·The Journal of Biological Chemistry·T U HaS Maheswaran
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·A E StephenD T MacLaughlin
May 18, 2001·The Journal of Biological Chemistry·D L SegevS Maheswaran
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Dorry L SegevShyamala Maheswaran
Feb 1, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Hans K LorenzoDavid T MacLaughlin
Oct 9, 2002·Nature Genetics·Soazik P JaminRichard R Behringer
Feb 6, 2003·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Oct 9, 2003·The Journal of Biological Chemistry·Yasunori HoshiyaShyamala Maheswaran
Dec 6, 2003·Molecular and Cellular Endocrinology·Yasunori HoshiyaShyamala Maheswaran
Dec 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Thanh U BarbiePatricia K Donahoe
Dec 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·Elizabeth J RenaudPatricia K Donahoe
Feb 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·V GuptaS Maheswaran

❮ Previous
Next ❯

Citations

Mar 14, 2014·Endocrine-related Cancer·Raymond R Y WongYick Fu Wong
Jul 20, 2006·Proceedings of the National Academy of Sciences of the United States of America·Paul P SzotekPatricia K Donahoe
Nov 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rafael Pieretti-VanmarckeDavid T MacLaughlin
Mar 27, 2015·International Journal of Cancer. Journal International Du Cancer·Anniina FärkkiläLeila Unkila-Kallio
Jul 29, 2015·Proceedings of the National Academy of Sciences of the United States of America·David PépinPatricia K Donahoe
Sep 17, 2009·Protein Expression and Purification·Thanos D PapakostasDemetrios Vavvas
Jun 1, 2012·Acta Obstetricia Et Gynecologica Scandinavica·Anna Garcia-Alix GrynnerupSteen Sørensen
Jul 15, 2015·The Journal of Endocrinology·Ian S McLennan, Michael W Pankhurst
Feb 26, 2013·Cancer Treatment Reviews·Francesca RicciGiovanna Damia
Sep 30, 2014·Obstetrics & Gynecology Science·Jang Heub KimPatricia K Donahoe
Dec 7, 2013·PloS One·Lauriane SèdesSoazik P Jamin
Sep 19, 2017·International Journal of Cancer. Journal International Du Cancer·Seungyoun JungJoanne F Dorgan
Aug 3, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·Mikko AnttonenMarkku Heikinheimo
Jul 11, 2009·Endocrine Reviews·F J BroekmansB C Fauser
Jun 24, 2017·Journal of Assisted Reproduction and Genetics·Vitaly A KushnirNorbert Gleicher
Mar 20, 2019·International Journal of Molecular Sciences·Marek GowkielewiczMarta Majewska
Dec 25, 2019·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alba Rodriguez-GarciaDaniel J Powell
Oct 21, 2010·Journal of Ovarian Research·Bridget A QuinnDenise C Connolly

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.